| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/16/2002 | CN1331585A Spray on bandage and drug delivery system |
| 01/16/2002 | CN1331584A Method for preparing effervescent granulate comprising iron gluconate granulate thus obtained and tablets containing same |
| 01/16/2002 | CN1331583A Process for producing spherical fine particles contg drug |
| 01/16/2002 | CN1331582A Propofol compsn. comprising gentetate |
| 01/16/2002 | CN1331581A Pharmaceutical aerosol compsn. contg. HFA227 and HFA 137 |
| 01/16/2002 | CN1331580A Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
| 01/16/2002 | CN1331576A Methods and transdermal compsns. for pain relief |
| 01/16/2002 | CN1331575A Methods and appts. for improved administration of fentanyl and supentanil |
| 01/16/2002 | CN1330956A Permanent-magnet colloid for plastic self-viscose magnetcally osmosizing ointment and its preparing process |
| 01/16/2002 | CN1330952A Concentrated tablet of single Chinese-medicinal material |
| 01/16/2002 | CN1330947A Buccal acanthopanax bark lozenge and its preparing process |
| 01/16/2002 | CN1330946A Process for preparing garlic injection |
| 01/16/2002 | CN1330934A Process for preparing Chinese medicine |
| 01/16/2002 | CN1330921A Method of mfg. slowly-released microball by combined milk process |
| 01/16/2002 | CN1330920A Process for preparing granular ibuprofen |
| 01/16/2002 | CN1330919A Plastic self-viscose magnetically osmosiring ointment and its preparing process |
| 01/16/2002 | CN1077800C Cyclosporin soft capsule compsn. |
| 01/16/2002 | CN1077792C Pyridylbisphosphonates for use as therapeutical agent |
| 01/16/2002 | CN1077790C Agent for treating gluaucoma and agent for reducing eye pressure |
| 01/16/2002 | CN1077774C Bioactive feed |
| 01/15/2002 | USRE37516 Acetamide derivative having defined particle size |
| 01/15/2002 | US6339173 For interfering with protein expression in a cell; useful in lipid aggregates for the delivery of macromolecules into cells |
| 01/15/2002 | US6339107 Methods for treatment of Emphysema using 13-cis retinoic acid |
| 01/15/2002 | US6339086 Administering n-desmethylzopiclone, or its pharmaceutically acceptable salt, solvate, hydrate, or clathrate for prophylaxis or therapy of anxiety |
| 01/15/2002 | US6339069 Administering formulation comprising pharmaceutically acceptable carrier; and, liposome comprising a bioactive agent and a lipid component, the lipid component comprising a peptide-lipid conjugate |
| 01/15/2002 | US6339060 For therapy of infections caused by microorganisms |
| 01/15/2002 | US6338859 Polymeric micelle compositions |
| 01/15/2002 | US6338857 Sustained release compositions with cores of carbamazepine and hydroxypropyl methyl cellulose and coating |
| 01/15/2002 | US6338843 Polysaccharide dextrin bonded to doxorubicin |
| 01/15/2002 | CA2094727C Hydrogen-containing chlorofluorocarbon aerosol medicaments |
| 01/15/2002 | CA2094726C Non-chlorofluorocarbon aerosol formulation comprising a particulate medicament |
| 01/15/2002 | CA2090479C Stock solution of sucralfate suspended in water and production thereof |
| 01/15/2002 | CA2059725C Diluent for perfluorocarbons employed for retinal unfolding (unfolding pfcl) |
| 01/15/2002 | CA2050946C Use of polysaccharides in preparations for wound treatment |
| 01/15/2002 | CA2038672C Dosage form for delivering drug to the intestine |
| 01/15/2002 | CA2035403C Washing compounds containing non soluble silicone and a surfactant agent of the polyoxyalkyl carboxylic etheracid tye and their applica tion in the field of cosmetology and dermatology |
| 01/14/2002 | CA2352496A1 Oral solid pharmaceutical formulations with ph-dependent multiphasic release |
| 01/10/2002 | WO2002002745A2 Method and system for consistent and effective encapsulation of biological material |
| 01/10/2002 | WO2002002716A2 Cubic liquid crystalline compositions and methods for their preparation |
| 01/10/2002 | WO2002002645A1 COLD WATER SOLUBLE β-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 01/10/2002 | WO2002002643A1 Cellulose powder |
| 01/10/2002 | WO2002002607A2 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002509A1 Compounds and compositions for delivering active agents |
| 01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002222A1 Method for producing capsules containing an active ingredient and having an ultra-thin coating |
| 01/10/2002 | WO2002002189A2 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 01/10/2002 | WO2002002182A2 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system |
| 01/10/2002 | WO2002002177A1 Auxiliary device for sticking pasting agent |
| 01/10/2002 | WO2002002145A2 Composition for aqueous stabilization of fat-soluble vitamins |
| 01/10/2002 | WO2002002139A2 Methods and composition for oral vaccination |
| 01/10/2002 | WO2002002138A1 Treating endotoxemia and related disorders with probiotics |
| 01/10/2002 | WO2002002136A1 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 01/10/2002 | WO2002002130A1 Anti-viral composition |
| 01/10/2002 | WO2002002128A2 Oral compositions comprising antimicrobial agents |
| 01/10/2002 | WO2002002126A1 Medicaments containing dextrin for treating respiratory disorders such as cystic fibrosis |
| 01/10/2002 | WO2002002125A1 Injectable composition |
| 01/10/2002 | WO2002002124A1 Compositions containing ascorbic acid phosphoric acid esters |
| 01/10/2002 | WO2002002111A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 01/10/2002 | WO2002002106A1 Use of modified tall oil in combination with dietary supplements to improve body composition and health status |
| 01/10/2002 | WO2002002103A2 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 01/10/2002 | WO2002002096A2 Oral compositions comprising host-response modulating agent |
| 01/10/2002 | WO2002002085A2 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 01/10/2002 | WO2002002084A1 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| 01/10/2002 | WO2002002083A1 Tablet rapidly disintegrating in mouth and process for producing the same |
| 01/10/2002 | WO2002002082A2 Use of dicalcium phosphate anhydride powder |
| 01/10/2002 | WO2002002081A1 Rapid-melt semi-solid compositions, methods of making same and methods of using same |
| 01/10/2002 | WO2002002080A1 Rapid-melt semi-solid compositions, methods of making same and methods of using same |
| 01/10/2002 | WO2002002079A1 Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
| 01/10/2002 | WO2002002078A2 Improved liposomal camptothecins and uses thereof |
| 01/10/2002 | WO2002002077A2 Liposomal antineoplastic drugs and uses thereof |
| 01/10/2002 | WO2002002076A2 Methods for treating inflammation-mediated conditions of the eye |
| 01/10/2002 | WO2002002059A1 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| 01/10/2002 | WO2002002056A2 Method of treatment of seborrheic dermatitis |
| 01/10/2002 | WO2002001962A2 A positive hydration method of preparing confectionery and the resulting product |
| 01/10/2002 | WO2002001954A1 Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury |
| 01/10/2002 | WO2001070291A3 Injectable microspheres for dermal augmentation and tissue bulking |
| 01/10/2002 | WO2001056611B1 Oral delivery of allergens in milk |
| 01/10/2002 | WO2001051066A3 Reduction in bacterial colonization by administering bacteriophage compositions |
| 01/10/2002 | WO2001051027A3 Polymer blends as biodegradable matrices for preparing biocomposites |
| 01/10/2002 | WO2001043762A3 Polypeptide compositions with improved stability |
| 01/10/2002 | WO2001043660A3 Porous three dimensional structure |
| 01/10/2002 | WO2001037896A3 Methods and compositions for administration of therapeutic reagents |
| 01/10/2002 | WO2001035946A3 Intranasal administration of raloxifene and tamoxifen |
| 01/10/2002 | WO2001035927A3 Topical application of muscarinic analgesic drugs such as neostigmine |
| 01/10/2002 | WO2001034118A3 Solid dispersion pharmaceutical formulations |
| 01/10/2002 | WO2001032616A3 Oxetanone derivatives |
| 01/10/2002 | WO2001030804A3 Salt form of a conjugate useful in the treatment of prostate cancer |
| 01/10/2002 | WO2001030408A3 Adhesive composition over a bioactive polymerization initiator |
| 01/10/2002 | WO2001028535A3 Pharmaceutical formulations comprising a combination of s-salmeterol and fluticasone propionate |
| 01/10/2002 | US20020004942 Transgenic plant that expresses luciferase; for use in the development of toys, foods, textiles and beverages that glow |
| 01/10/2002 | US20020004678 Surgical stent and method for preventing occlusion of stented vessels and conduits after implantation of stents |
| 01/10/2002 | US20020004585 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 01/10/2002 | US20020004532 Low emulsifier multiple emulsions |
| 01/10/2002 | US20020004529 Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| 01/10/2002 | US20020004524 Administering 15-keto-prostaglandin |
| 01/10/2002 | US20020004506 In binder film |
| 01/10/2002 | US20020004499 Mixture of antibiotics; variations of releasing profiles |
| 01/10/2002 | US20020004498 Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |